MedTech’s Got Talent National Finals 2018

Five teams have made it to the 2018 National MedTech’s Got Talent National Finals after pitching their business concept to the judging panel of industry executives. Each team secured $10,000 non-dilutive, stage-gated funding to kickstart their MedTech startup towards product-market fit and investor readiness. These teams will participate in an intensive 6-week accelerator program, with the most investible team taking out the competition, and receiving an additional $30,000.

The 2018 MedTech’s Got Talent finalists are:


Real time monitoring of pressure delivered to lungs in neonatal intensive care; Team: Edward Buijs, Lorinda Hartley, Amy Yu, Seetal Erramilli and Alan Haszard; mentored by Design and Industry

Enlighten Imaging

Transforming the way in which Alzheimer’s disease is detected; Team: Dr. Lauren Giorgio Peter van Wijngaarden, Xavier Hadoux and Professor Darren Kelly; mentored by Vestech


Instant unambiguous cellular diagnosis; Team: Associate Professor Brian Abbey, Dr. Eugeniu Balaur, Dr. Caroline Bathje and Dr. Belinda Parker; mentored by Hydrix


Complete patient transfer system; Team: Simone Saville, Dr. Cameron Keating, Jane Chen, Sidonie Matthew and Garrick Liu; mentored by The Actuator


Harnessing technology to explore language in a child’s real-world to accelerate their development; Entrepreneur: Annie McAuley; mentored by IDE

People’s Choice Award

The $1,000 People’s Choice Award for the night was taken out by Horizen who are developing a device for the prediction of agitation in dementia patients.

Ventora and Horizen developed their respective invention as part of the Master of Engineering (BioDesign) that is offered by the Department of Biomedical Engineering at The University of Melbourne.

We are also delighted that Enlighten Imaging made to finals as the team was a finalist at the 2018 HealthTech Innovation Challenge that is organised by the Graeme Clark Institute for Biomedical Engineering in partnership with the Melbourne Academic Centre for Health.

Each of these teams will begin an intensive six-week training program focused on the critical issues for MedTech start-ups, such as clinical need validation, regulatory strategy, intellectual property protection, and reimbursement.

The program will conclude in March 2018 with an Investor Deal Pitch where the overall ‘most investable team’ will then receive an additional stage-gated $30,000 with no impact on equity or IP.